Synchrony-Optimized Non-Invasive Ventilation Education Program and ICU Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShahid Beheshti University of Medical Sciences

About this trial

The aim of this clinical trial is to find out whether a synchrony-optimized education program for non-invasive ventilation (NIV) can help ICU patients use their ventilator more effectively and improve their comfort, symptoms, and psychological well-being.

Researchers want to answer these main questions:

Can a structured two-session NIV education program help patients use their ventilator more regularly and for longer periods?

Does this type of training reduce anxiety, depression, and respiratory symptoms?

Can synchrony training improve patients' comfort and reduce NIV-related problems such as mask leaks or sleep disturbances?

Is this program more effective than the routine ICU education normally provided?

What Will Happen in the Study

Adults (18+) who are receiving NIV in the ICU will participate in this study.

Participants will be randomly assigned to one of two groups:

Intervention Group: Will receive the SYNC-NIV education program, consisting of:

One hands-on session (20-40 minutes) teaching patients how to synchronize their breathing with the ventilator

One supplementary session (45-60 minutes) covering mask management, preventing complications, reducing leaks, breathing exercises, equipment care, and alarm handling

An educational booklet for continued support

Control Group: Will receive the standard ICU education normally provided about the ICU environment, general care, communication, and monitoring.

All participants will be evaluated at three times:

before the intervention, the day after the program ends, and one week later.

Eligibility criteria

Qualifiers

Adult patients over 18 years of age

Admitted to the ICU for at least 24 hours

Anticipated to be hospitalized for more than one week

Receiving NIV treatment for any underlying condition

Disqualifiers

Patients with Richmond Agitation-Sedation Scale (RASS) scores of +4 or -5

Patients with cognitive disorders

Patients with neurological disorders

Patients with anxiety disorders

Trial design

Treatments tested in this trial

  • SYNC-NIV

Treatment groups

92 Participants
are divided into 2 treatment groups

Locations

This trial has no locations